the effect of Rosa Damascena Mill on constipation in pregnancy

Evaluation of the effect of Rosa Damascena Mill product on constipation in pregnancy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190427043388N1

Enrollment

Registered

2019-07-05

Start date

2019-01-20

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation in pregnancy. constipation

Interventions

Intervention group: Rosa Damascena Mill product (750 mg) daily for 4 weeks.

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Healthy pregnant women with constipation based on ROME III criteria Age over 18 and under 45 years Patient's consent to participation in the study Pregnancy Week 14-34 Not using of medicine to treatment constipation The absence of a history of anorectal disease

Exclusion criteria

Exclusion criteria: Lack of willingness to cooperate Medicinal sensibility pregnancy and midwifery problem (ROM, Premature Labour, Placeta abruption, pre eclampsia) anorectal disease Use of other medication during treatment Any problem lead to patient bed

Design outcomes

Primary

Measure	Time frame
Constipation score. Timepoint: Before intervention, after 2 weeks, after 4 weeks. Method of measurement: Constipation Questionnaire based on Rome III criteria.;Quality of Life score. Timepoint: Before intervention, after 4 weeks. Method of measurement: WHO Quality of Life Questionnaire.	—

Secondary

Measure	Time frame
Rosa Damascena Mill product use frequency. Timepoint: End of week 4. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNafiseh Nili

Shahed University

dr.nili64@gmail.com+98 21 5121 4056

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026